DR.REDDY'S Laboratories LIMITED

Form 483 issued October 30, 2018 · Visakhapatnam, India

Inspection
Oct 22 – Oct 30, 2018
Observations
1
Pages
10
FEI number
3006549835

In short: On October 30, 2018, FDA issued a Form 483 with 1 observation to DR.REDDY'S Laboratories LIMITED in Visakhapatnam, India (FEI 3006549835) after an inspection that ran Oct 22 – Oct 30, 2018. The investigators were Jose E. Melendez and Junho Pak. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There are no written procedures for production and process controls designed to assure that the drug…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at DR.REDDY'S Laboratories LIMITED?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected DR.REDDY'S Laboratories LIMITED?

Jose E. Melendez and Junho Pak are named on this Form 483, for the inspection of Oct 22 – Oct 30, 2018. Each investigator has a profile showing what they cite most.

When was DR.REDDY'S Laboratories LIMITED inspected by FDA?

The inspection ran Oct 22 – Oct 30, 2018, and the Form 483 is dated October 30, 2018.

How do I get the full Form 483 for DR.REDDY'S Laboratories LIMITED?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free